Analyst Research

Report Title Price
Provider: Wright Reports
$169.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Takeda Pharmaceutical Co Ltd Reiterates FY 2014 Guidance-Conference Call


Thursday, 31 Oct 2013 04:30am EDT 

Takeda Pharmaceutical Co Ltd announced that it is reiterating its fiscal 2014 guidance with net sales at JPY1,680 billion and operating income at JPY140 billion. 

Company Quote

6084.0
-24.0 -0.39%
1:30am EDT